Fe Pharmaceuticals was founded to develop unique, purpose-designed, iron management polymers as therapeutic treatments to alter the course of serious diseases in patients.
Fe Pharmaceuticals was founded to develop unique, purpose-designed, iron management polymers as therapeutic treatments to alter the course of serious diseases in patients.
DIBI (Denying Iron to Bacterial Infections) is a polymer built to bind iron tighter than any pathogen molecules. Each molecule of DIBI to bind three iron molecules completely.